Skip to content

Ultrasound-Guided Subtransverse Interligamentary Block Versus Thoracic Paravertebral Block for Postoperative Analgesia in Patients Undergoing Open Nephrectomy

Ultrasound-Guided Subtransverse Interligamentary Block Versus Thoracic Paravertebral Block for Postoperative Analgesia in Patients Undergoing Open Nephrectomy: A Randomized Clinical Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07138794
Enrollment
70
Registered
2025-08-24
Start date
2025-08-23
Completion date
2026-04-01
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Nephrectomy, Postoperative Analgesia, Subtransverse Interligamentary Block, Thoracic Paravertebral Block

Brief summary

This study aims to compare ultrasound-guided subtransverse process interligamentary (STIL) block versus thoracic paravertebral block (TPVB) for postoperative analgesia in patients undergoing open nephrectomy.

Detailed description

Acute pain physiopathology is explained as it is mediated by inflammatory cell infiltration, activation of spinal cord pain pathways, and also by reflexive muscle spasm. All of these three mechanisms of acute pain are typically ameliorated during the postoperative recovery. A thoracic paravertebral block (TPVB) shows comparable analgesic efficacy with fewer side effects compared with thoracic epidural analgesia in patients undergoing thoracotomy. The recently introduced subtransverse process interligamentary (STIL) block offers a safer alternative by targeting thoracic nerves without entering paravertebral space.

Interventions

OTHERSubtransverse process interligamentary

Patients will receive subtransverse process interligamentary (STIL) block using 20ml of bupivacaine 0.25%.

OTHERThoracic paravertebral block

Patients will receive a thoracic paravertebral block (TPVB) using 20ml of bupivacaine 0.25%.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-III. * Undergoing open nephrectomy under general anesthesia.

Exclusion criteria

* History of allergies to local anesthetics. * Opioid dependency. * Bleeding or coagulation disorders. * Psychiatric and neurological disorder. * Local infection at the site of injection. * Body mass index (BMI) \> 35 kg/m2. * Severe heart, lung, liver, and renal dysfunction. * Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frameDescription
Total morphine consumption48 hours postoperativelyRescue analgesia of morphine will be given as 3 mg bolus if the numeric rating scale (NRS) \> 3 to be repeated after 30 min if pain persists until the NRS \< 4.

Secondary

MeasureTime frameDescription
Time to the 1st rescue analgesia48 hours postoperativelyTime to the first request for the rescue analgesia will be recorded from the end of surgery to first dose of morphine administrated.
Intraoperative fentanyl consumptionIntraoperativelyAdditional fentanyl bolus dosages of 0.5 µg/kg IV will be administered if heart rate or mean arterial blood pressure elevated more than 20% of the baseline (after exclusion of other causes than pain).
Mean arterial pressureTill the end of surgery (Up to 2 hours)Mean arterial pressure will be recorded preoperatively, before performing the block, and every 15 min till the end of surgery.
Heart rateTill the end of surgery (Up to 2 hours)Heart rate will be recorded preoperatively, before performing the block, and every 15 min till the end of surgery.
Degree of pain48 hours postoperativelyEach patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS will be assessed at PACU, 2, 4, 6, 8, 12, 18, 24, 36, and 48 h postoperatively.
Incidence of adverse events48 hours postoperativelyIncidence of adverse events such as pneumothorax, local anesthetic systemic toxicity (LAST), bradycardia, hypotension, nausea, vomiting, respiratory depression, pruritus, or any other complication will be recorded.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026